Table 1

Patient characteristics (ambulatory patch and historical unmatched comparator cohorts)

CharacteristicAmbulatory patch cohortnHistorical unmatched comparator cohortn
Demographic data
 Age/years62.8±19.58667.5±19.5603
 Male sex46 (53)86281 (47)603
Examination findings
 Pulse/bpm73.7±14.98674.9±15.8601
 Blood sugar/mmol/L6.6±2.1817.0±2.3558
 Systolic BP/mm Hg138.6±27.186133.4±24.5597
 Diastolic BP/mm Hg75.9±17.58668.6±13.3596
 Postural drop (>20 mm Hg on standing)4 (7.0)5741 (10.9)375
 Systolic difference if performed11.1±10.63115.7±10.9131
 Saturation ≤94% on admission on room air4 (4.7)8640 (6.8)587
 Saturation ≤94% on admission on O2 21 (24.4)86
 Bradycardia ≤50 in ED or prehospital6 (7.0)86n/an/a
Examination
 Heart murmur heard6 (7.0)8685 (14.5)586
 Clinical signs of heart failure present3 (3.5)8648 (8.1)593
 New neurological signs on examination0 (0)8610 (1.7)600
 FOB/Melena on PR0 (0)106 (7.1)87
History of syncopal episode
 Subjective SOB6 (7.0)8665 (10.8)603
 Prodromal/preceding symptoms41 (47.7)86326 (54.1)603
 Palpitations prior to syncope3 (3.5)8615 (2.5)603
 Associated chest pain5 (5.8)8655 (9.1)603
 Associated headache4 (4.7)8661 (10.1)603
 Situational symptoms, that is, micturition6 (7.0)8640 (6.6)603
 Related to GTN use0 (0)8612 (2.0)603
 Related to exertion5 (5.8)8638 (6.3)603
 Witnessed seizure activity2 (2.3)8613 (2.2)602
 Estimated length of loss of consciousness/min1.5 (1–3)*58n/an/a
Medical history
 Previous episodes of syncope36 (41.9)86251 (41.8)600
 >1 episode in the last year17 (19.8)86109 (18.2)600
 Previous hypertension35 (40.7)86254 (42.2)602
 Known ischaemic heart disease11 (12.8)86146 (24.2)603
 Previous myocardial infarct4 (4.7)8675 (12.5)602
 Known history of valvular heart disease4 (4.7)8640 (6.6)602
 Previous history of cardiac arrest1 (1.2)868 (1.3)602
 Known history of cardiac failure5 (5.8)8634 (5.6)602
 Pacemaker0 (0)8615 (2.5)603
 Implantable defibrillator0 (0)864 (0.7)603
Management of index event
 Admitted39 (45.3)86396 (65.7)603
 Discharged from ED with planned outpatient clinic appointment15 (17.4)8647 (7.8)603
 Discharged from ED with GP follow-up only32 (37.3)86160 (26.5)603
 Referred to hospital cardiac electrophysiology service (prior to patch report)0 (0)86n/an/a
Reason(s) for admission:
 High-risk syncope
 Comorbidity
 Syncope investigation
 Social reasons
 Other
20 (51.3)
0 (0)
12 (30.8)
0 (0)
7 (17.9)
39n/an/a
Treating clinician likelihood of underlying cardiac cause of syncope:
 0 Least likely
 1
 2
 3
 4
 5
 6
 7
 8
 9
 10 Most likely
2 (2.4)
7 (8.2)
13 (15.3)
12 (14.1)
11 (12.9)
10 (11.8)
10 (11.8)
9 (10.6)
5 (5.9)
5 (5.9)
1 (1.2)
4.5±2.5
85n/an/a
Admission ECG findings
 Rate73.2±22.18673.7±16.7545
 QRS axis42.0±38.87516.8±47.0333
 QTc int433.0±32.786423.3±34.4530
 Sinus rhythm81 (94.2)86498 (91.4)545
 PR >200 ms (first degree heart block)14 (16.3)8674 (13.6)545
 Mobitz type II/Wenkebach heart block0 (0)860 (0)545
 Bifascicular block/trifascicular block0 (0)867 (1.3)545
 Complete heart block0 (0)862 (0.4)545
 Sinus bradycardia <504 (4.7)8611 (2.0)545
 Sinus pause >3 s0 (0)860 (0)545
 ST elevation >1 mm3 (3.5)8626 (4.8)545
 T wave inversion14 (16.3)86138 (25.3)545
 ST segment depression >1 mm0 (0)8637 (6.8)545
 Q wave (not in lead III)4 (4.7)86112 (20.6)544
 QRS duration ≥120 ms4 (4.7)8647 (8.6)544
 Number of ventricular ectopics >06 (7.0)8641 (7.6)543
 Atrial tachycardia (including AF) >1000 (0)869 (1.7)545
 Narrow complex tachycardia >1004 (4.7)8629 (5.3)545
 Broad complex tachycardia >1001 (1.2)862 (0.4)545
Admission lab findings
 Hb/g/L136.1 (16.6)85132.0 (17.3)595
 eGFR >6065 (76.5)85390 (66.2)592
  • Values are presented as mean±SD or n (%) unless stated * median (IQR). AF, atrial fibrillation; eGFR, estimated glomerular filtration rate; FOB, faecal occult blood; GTN, glyceryl trinitrate; Hb, haemoglobin; PR, per rectum; QRS, QRD wave complex; QTc int, QT interval corrected; SOB, shortness of breath.